Meyka Pro banner
Genenta Science S.p.A.

Genenta Science S.p.A. Fundamental Analysis (NASDAQ: SAEN)

SAEN●NASDAQ
IndustrialsConglomerates
$0.51
$0.05(9.39%)
U.S. Market opens in 24h 10m

Genenta Science S.p.A. Fundamental Analysis (NASDAQ: SAEN)

Genenta Science S.p.A. (NASDAQ: SAEN) shows weak financial fundamentals with a PE ratio of -1.40, profit margin of 0.00%, and ROE of -36.82%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position265.33%
PEG Ratio-0.04
Current Ratio14.16

Areas of Concern

ROE-36.82%
Operating Margin0.00%
We analyze SAEN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -13.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-13.6/100

We analyze SAEN's fundamental strength across five key dimensions:

Efficiency Score

Weak

SAEN struggles to generate sufficient returns from assets.

ROA > 10%
-19.60%

Valuation Score

Excellent

SAEN trades at attractive valuation levels.

PE < 25
-1.40
PEG Ratio < 2
-0.04

Growth Score

Weak

SAEN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

SAEN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.35
Current Ratio > 1
14.16

Profitability Score

Weak

SAEN struggles to sustain strong margins.

ROE > 15%
-3681.79%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is SAEN Expensive or Cheap?

P/E Ratio

SAEN trades at -1.40 times earnings. This suggests potential undervaluation.

-1.40

PEG Ratio

When adjusting for growth, SAEN's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Genenta Science S.p.A. at 0.45 times its book value. This may indicate undervaluation.

0.45

EV/EBITDA

Enterprise value stands at -3.44 times EBITDA. This is generally considered low.

-3.44

How Well Does SAEN Make Money?

Net Profit Margin

For every $100 in sales, Genenta Science S.p.A. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-36.82 in profit for every $100 of shareholder equity.

-36.82%

ROA

Genenta Science S.p.A. generates $-19.60 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.60%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.36 in free cash annually.

$-0.36

FCF Yield

SAEN converts -35.13% of its market value into free cash.

-35.13%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.35

vs 25 benchmark

Current Ratio

Current assets to current liabilities

14.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.37

vs 25 benchmark

ROA

Return on assets percentage

-0.20

vs 25 benchmark

ROCE

Return on capital employed

-0.21

vs 25 benchmark

How SAEN Stacks Against Its Sector Peers

MetricSAEN ValueSector AveragePerformance
P/E Ratio-1.4025.53 Better (Cheaper)
ROE-36.82%1246.00% Weak
Net Margin0.00%-2622.00% (disorted) Weak
Debt/Equity0.350.75 Strong (Low Leverage)
Current Ratio14.1621.70 Strong Liquidity
ROA-19.60%-1325086.00% (disorted) Weak

SAEN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Genenta Science S.p.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

EPS CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

FCF CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

Fundamental Analysis FAQ